These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6506821)

  • 1. [Longitudinal studies on the prognostic significance of plasma fibrinogen in diabetes mellitus].
    Schmechel H; Beiküfner P; Panzram G
    Z Gesamte Inn Med; 1984 Sep; 39(18):453-7. PubMed ID: 6506821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of various hemorheologic parameters in diabetes mellitus].
    Cella A; Bianchi E; Reali GL; Piana A; Armani U
    Boll Soc Ital Biol Sper; 1990 Apr; 66(4):335-42. PubMed ID: 2390223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased plasma markers of inflammation and endothelial dysfunction and their association with microvascular complications in Type 1 diabetic patients without clinically manifest macroangiopathy.
    Targher G; Bertolini L; Zoppini G; Zenari L; Falezza G
    Diabet Med; 2005 Aug; 22(8):999-1004. PubMed ID: 16026364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rheological changes in diabetic microangiopathy.
    Negrean V; Suciu I; Sâmpelean D; Cozma A
    Rom J Intern Med; 2004; 42(2):407-13. PubMed ID: 15529630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitrite plasma levels in type 1 and 2 diabetics with and without complications.
    Ferlito S; Gallina M
    Minerva Endocrinol; 1999; 24(3-4):117-21. PubMed ID: 10953727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemostasiological parameters as risk factor for new arterial occlusions in diabetics.
    Breddin HK; Krzywanek HJ; Althoff P; Kirchmaier CM; Rosak C; Schepping M; Weichert W; Ziemen M; Schöffling K; Uberla K
    Klin Wochenschr; 1986 Oct; 64(20):1042-6. PubMed ID: 3491249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of blood glucose on the course of cerebral ischemia].
    Mast H; Seyfert S; Marx P
    Nervenarzt; 1989 May; 60(5):276-9. PubMed ID: 2739819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total homocysteine levels relation with chronic complications of diabetes, body composition, and other cardiovascular risk factors in a population of patients with diabetes mellitus type 2.
    de Luis DA; Fernandez N; Arranz ML; Aller R; Izaola O; Romero E
    J Diabetes Complications; 2005; 19(1):42-6. PubMed ID: 15642489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fibrinolytic system in patients with myocardial infarction and other coronary disease risk factors].
    Moreno JA; Gálvez MM; Cornudella R; Angós JA; Romero MS; Gutiérrez M
    Sangre (Barc); 1994 Apr; 39(2):111-6. PubMed ID: 8059288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Modification of hemorheological parameters in microvascular complications of diabetes].
    Bauduceau B; Renaudeau C; Mayaudon H; Hélie C; Ducorps M; Sonnet E; Yvert JP
    Diabete Metab; 1995 Jun; 21(3):188-93. PubMed ID: 7556810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fibrinogen and diabetic microangiopathy].
    Mojto V
    Vnitr Lek; 1997 Feb; 43(2):81-6. PubMed ID: 9245073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitrite plasma levels in type 1 and 2 diabetics with and without complications.
    Ferlito S; Gallina M
    Panminerva Med; 1998 Dec; 40(4):304-8. PubMed ID: 9973826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences between plasma viscosity and proteins of types 1 and 2 diabetic Africans in early phase of diabetes.
    Memeh CU
    Horm Metab Res; 1993 Jan; 25(1):21-3. PubMed ID: 8428705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognostic significance of the resting ECG of diabetics--results of a 10-year analysis].
    Schmechel H; Lippold C
    Z Gesamte Inn Med; 1983 Dec; 38(23):637-40. PubMed ID: 6670339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinogen and plasminogen activator inhibitor-1 level in peripheral arterial disease of type 2 diabetes patients.
    Hutajulu SH; Kurnianda J; Purwanto I; Asdie RH; Wiyono P; Asdie AH
    Acta Med Indones; 2006; 38(3):126-9. PubMed ID: 16953028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Plasma, erythrocyte and platelet magnesium in essential hyperTension, diabetes mellitus without and with macrovascular complications and atherosclerotic vascular disease].
    Grifò G; Lo Presti R; Montana M; Canino B; Caimi G
    Recenti Prog Med; 1995 Nov; 86(11):431-6. PubMed ID: 8539474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Significance of increased endothelin level for development of sequelae of diabetes mellitus].
    Haak T; Jungmann E; Hillmann U; Felber A; Usadel KH
    Med Klin (Munich); 1993 May; 88(5):291-6. PubMed ID: 8326915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fibrinogen-fibrin degradation products in diabetes mellitus].
    Alakhverdian R; Koev D
    Vutr Boles; 1987; 26(6):72-5. PubMed ID: 3125689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of the onset and progression of peripheral neuropathy and hypertension in NIDDM].
    Jarmuzewska EA; Ghidoni A
    Minerva Med; 2000; 91(1-2):1-15. PubMed ID: 10858728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of elevated biomarkers in diabetic and non-diabetic patients admitted for acute coronary syndromes.
    Fazel R; Fang J; Kline-Rogers E; Smith DE; Eagle KA; Mukherjee D
    Heart; 2005 Mar; 91(3):388-90. PubMed ID: 15710734
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.